Just over a month ago, we completed an exciting and important acquisition of the remaining equity in our drug discovery holding, ReceptoPharm. Even though it has taken more than a year and a half since we first signed a letter of intent to acquire them, we are just as excited today as we were in [...]
|
||||
|
||||||
